Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bayer Aktiengesellschaft (BAYN.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
57.00+0.64 (+1.14%)
At close: 08:47PM CET
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close56.36
Open56.18
Bid56.80 x 120000
Ask57.30 x 120000
Day's Range56.12 - 57.18
52 Week Range46.90 - 67.95
Volume3,825
Avg. Volume5,357
Market Cap56.102B
Beta (5Y Monthly)1.13
PE Ratio (TTM)N/A
EPS (TTM)-10.69
Earnings DateFeb 28, 2023
Forward Dividend & Yield2.00 (3.93%)
Ex-Dividend DateMay 02, 2022
1y Target EstN/A
  • Reuters

    Bayer investor calls for swift replacement of CEO: newspaper

    Bayer investor Deka has called for CEO Werner Baumann to be replaced ahead of his scheduled departure, adding to mounting pressure on the German drugmaker. "Bayer needs a new strategic positioning, which cannot be credibly accomplished under Werner Baumann," Ingo Speich, head of sustainability and corporate governance at Deka, told the Frankfurter Allgemeine Sonntagszeitung (FAS) newspaper in remarks published on Saturday. The mutual funds firm is among Bayer's 20 largest shareholders.

  • Financial Times

    Bayer: activist could revive fortunes of chemical group

    Does Bayer’s C-suite have sufficient chemistry with its shareholders? The recent addition of two activist investors suggests maybe not. Jeff Ubben at Inclusive Capital Partners thinks the current management team is too tight-knit and wants Bayer to hire a new chief executive from outside.

  • Motley Fool

    The Top Healthcare Stocks to Buy With $100

    Bayer Aktiengesellschaft (OTC: BAYR.Y) and AstraZeneca (NASDAQ: AZN) are elite healthcare companies with shares that trade for less than $100 and make excellent long-term investments because of their revenue and earnings growth, promising pipelines, and above-average dividends. Bayer was down 11.2% in 2022 and currently trades for about $15 a share while AstraZeneca was up 16.4% in 2022 and currently trades for around $70 a share. Bayer is a huge German life science conglomerate.

Advertisement
Advertisement